Meet-the-Professor Session:
102. Curbsides in Transplant Infectious Diseases--Not So Fast, Not So Loose...
Friday, October 28, 2016: 7:00 AM-8:15 AM
Room: 291-292

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss practical approaches to common questions and problems encountered in day-to-day practice of Transplant Infectious Diseases
  • describe the level of evidence and consequences of diverse system-wide practices regarding prevention and treatment of selected infectious diseases of particular impact to transplant and oncology recipients
  • identify sources for answers to uncommon questions regarding diagnosis, treatment and prevention of infectious diseases in transplant and oncology questions

Please email your questions before the session to Session.Questions@idsociety.org, Dr. Francisco Marty (fmarty@bwh.harvard.edu), or Dr. Raymund Razonable (Razonable.Raymund@mayo.edu).


Session.Questions@idsociety.org


Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Infectious diseases pediatricians, Infectious diseases physicians, Members-in-training, Microbiologists, Nurses, Pharmacists

Tracks: Adult ID, Epidemiology and Infection Control, Global ID

Moderator:  Francisco M. Marty, MD, FIDSA, Brigham and Women's Hospital

Presentations:
7:00 AM
862
Meet-the-Professor
Lindsey R. Baden, MD
7:30 AM
863
Meet-the-Professor
Emily Blumberg, MD, FIDSA

8:00 AM
Q&A

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.25 knowledge-based contact hours 0.125 of pharmacy CE

ACPE Number: 0221-9999-16-249-L04-P

Disclosures:

F. M. Marty, Alexion: Scientific Advisor , Consulting fee
Ansun: Investigator , Research support
Astellas: Consultant and Investigator , Consulting fee and Research support
Basilea: Conference speaker , Speaker honorarium
Chimerix: Consultant and Investigator , Consulting fee and Research support
Gilead: Consultant and Investigator , Consulting fee and Research support
GlaxoSmithKline: Consultant and Investigator , Consulting fee and Research grant
LFB, S.A.: Consultant , Consulting fee
Merck: Consultant and Investigator , Consulting fee and Research support
Shire: Consultant and Investigator , Consulting fee and Research support
WHISCON: Investigator , Research support
Pfizer: Course speaker , Speaker honorarium
Fate Therapeutics: Scientific Advisor , Consulting fee

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.